The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Antiretroviral Drug Resistance Testing in Adult HIV‐1 Infection: 2008 Recommendations of an International AIDS Society–USA Panel
Open accessAbstract
Resistance to antiretroviral drugs remains an important limitation to successful human immunodeficiency virus type 1 (HIV-1) therapy. Resistance testing can improve treatment outcomes for infected individuals. The availability of new drugs from various classes, standardization of resistance assays, and the development of viral tropism tests necessitate new guidelines for resistance testing. The International AIDS Society-USA convened a panel of physicians and scientists with expertise in drug-resistant HIV-1, drug management, and patient care to review recently published data and presentations at scientific conferences and to provide updated recommendations. Whenever possible, resistance testing is recommended at the time of HIV infection diagnosis as part of the initial comprehensive patient assessment, as well as in all cases of virologic failure. Tropism testing is recommended whenever the use of chemokine receptor 5 antagonists is contemplated. As the roll out of antiretroviral therapy continues in developing countries, drug resistance monitoring for both subtype B and non-subtype B strains of HIV will become increasingly important.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Core Structure of gp41 from the HIV Envelope Glycoprotein
Chan, D. C., Fass, D., Berger, J. M., & Kim, P. S. (1997) · Cell · doi:10.1016/s0092-8674(00)80205-6 · Cited by 1,959
Gulick, R. M., Mellors, J. W., Havlir, D., Eron, J. J., Gonzalez, C., McMahon, D., Richman, D. D., Valentine, F. T., Jonas, L., Meibohm, A., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371102 · Cited by 1,885
Self-citationDiagnosis, management, and treatment of hepatitis C†
Strader, D. B., Wright, T., Thomas, D. L., & Seeff, L. B. (2004) · Hepatology · doi:10.1002/hep.20119 · Cited by 1,709
UPDATE ON DRUG RESISTANCE MUTATIONS IN HIV-1
&NA; (2001) · Infectious Diseases in Clinical Practice · doi:10.1097/00019048-200106000-00020 · Cited by 1,660
HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy
Larder, B. A., Darby, G., & Richman, D. D. (1989) · Science · doi:10.1126/science.2467383 · Cited by 1,559
Self-citationChan, D. C., & Kim, P. S. (1998) · Cell · doi:10.1016/s0092-8674(00)81430-0 · Cited by 1,277
Dorr, P., Westby, M., Dobbs, S., Griffin, P., Irvine, B., Macartney, M., Mori, J., Rickett, G., Smith-Burchnell, C., Napier, C., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4721-4732.2005 · Cited by 1,152
Antiretroviral-Drug Resistance among Patients Recently Infected with HIV
Little, S. J., Holte, S., Routy, J.-P., Daar, E. S., Markowitz, M., Collier, A. C., Koup, R. A., Mellors, J. W., Connick, E., Conway, B., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013552 · Cited by 1,140
Self-citationKim, R. B., Fromm, M. F., Wandel, C., Leake, B., Wood, A. J., Roden, D. M., & Wilkinson, G. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1269 · Cited by 1,054
Treatment for Adult HIV Infection: 2006 Recommendations of the International AIDS Society–USA Panel
Hammer, S. M., Saag, M. S., Schechter, M., Montaner, J. S. G., Schooley, R. T., Jacobsen, D. M., Thompson, M. A., Carpenter, C. C. J., Fischl, M. A., Gazzard, B. G., et al. (2006) · JAMA · doi:10.1001/jama.296.7.827 · Cited by 1,033
Self-citationWild, C. T., Shugars, D. C., Greenwell, T. K., McDanal, C. B., & Matthews, T. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9770 · Cited by 931
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women
Mosca, L., Appel, L. J., Benjamin, E. J., Berra, K., Chandra-Strobos, N., Fabunmi, R. P., Grady, D., Haan, C. K., Hayes, S. N., Judelson, D. R., et al. (2004) · Circulation · doi:10.1161/01.cir.0000114834.85476.81 · Cited by 917
American Association for the Study of Liver Diseases
Popper, H. (1960) · Gastroenterology · doi:10.1016/s0016-5085(60)80094-7 · Cited by 903
A Conserved HIV gp120 Glycoprotein Structure Involved in Chemokine Receptor Binding
Rizzuto, C. D., Wyatt, R., Hernández-Ramos, N., Sun, Y., Kwong, P. D., Hendrickson, W. A., & Sodroski, J. (1998) · Science · doi:10.1126/science.280.5371.1949 · Cited by 812
Sperling, R. S., Shapiro, D. E., Coombs, R. W., Todd, J. A., Herman, S. A., McSherry, G. D., O'Sullivan, M. J., Van Dyke, R. B., Jimenez, E., Rouzioux, C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611283352201 · Cited by 803
Hirsch, M. S., Brun-Vézinet, F., D'Aquila, R. T., Hammer, S. M., Johnson, V. A., Kuritzkes, D. R., Loveday, C., Mellors, J. W., Clotet, B., Conway, B., et al. (2000) · JAMA · doi:10.1001/jama.283.18.2417 · Cited by 766
Self-citationTreatment for Adult HIV Infection: 2004 Recommendations of the International AIDS Society-USA Panel
Yeni, P. G., Hammer, S. M., Hirsch, M. S., Saag, M. S., Schechter, M., Carpenter, C. C. J., Fischl, M. A., Gatell, J. M., Gazzard, B. G., Jacobsen, D. M., et al. (2004) · JAMA · doi:10.1001/jama.292.2.251 · Cited by 737
Self-citationWeb Resources for HIV Type 1 Genotypic-Resistance Test Interpretation
Liu, T. F., & Shafer, R. W. (2006) · Clinical Infectious Diseases · doi:10.1086/503914 · Cited by 654
Deeks, S. G., Wrin, T., Liegler, T., Hoh, R., Hayden, M., Barbour, J. D., Hellmann, N. S., Petropoulos, C. J., McCune, J. M., Hellerstein, M. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102153440702 · Cited by 653
A Novel Phenotypic Drug Susceptibility Assay for Human Immunodeficiency Virus Type 1
Petropoulos, C. J., Parkin, N. T., Limoli, K. L., Lie, Y., Wrin, T., Huang, W., Tian, H., Smith, D., Winslow, G. A., Capon, D. J., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.920-928.2000 · Cited by 646
Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004
Hemelaar, J., Gouws, E., Ghys, P. D., & Osmanov, S. (2006) · AIDS · doi:10.1097/01.aids.0000247564.73009.bc · Cited by 629
Gupta, S. K., Eustace, J. A., Winston, J. A., Boydstun, I. I., Ahuja, T. S., Rodriguez, R. A., Tashima, K. T., Roland, M., Franceschini, N., Palella, F. J., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/430257 · Cited by 581
MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs
Schuetz, J. D., Connelly, M. C., Sun, D., Paibir, S. G., Flynn, P. M., Srinivas, R. V., Kumar, A., & Fridland, A. (1999) · Nature Medicine · doi:10.1038/12487 · Cited by 575
O'Brien, W. A., Koyanagi, Y., Namazie, A., Zhao, J.-Q., Diagne, A., ldler, K., Zack, J. A., & Chen, I. S. Y. (1990) · Nature · doi:10.1038/348069a0 · Cited by 570
Hirsch, M. S., Conway, B., D'Aquila, R. T., Johnson, V. A., Brun-Vézinet, F., Clotet, B., Demeter, L. M., Hammer, S. M., Jacobsen, D. M., Kuritzkes, D. R., et al. (1998) · JAMA · doi:10.1001/jama.279.24.1984 · Cited by 563
Self-citationAntiretroviral Therapy for HIV Infection: A Knowledge-Based Approach to Drug Selection and Use
Moyle, G. J., Gazzard, B. G., Cooper, D. A., & Gatell, J. (1998) · Drugs · doi:10.2165/00003495-199855030-00005 · Cited by 536
Madruga, J. V., Cahn, P., Grinsztejn, B., Haubrich, R., Lalezari, J., Mills, A., Pialoux, G., Wilkin, T., Peeters, M., Vingerhoets, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61047-2 · Cited by 517
Hirsch, M. S., Brun‐Vezinet, F., Clotet, B., Conway, B., Kuritzkes, D. R., D’Aquila, R. T., Demeter, L. M., Hammer, S. M., Johnson, V. A., Loveday, C., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/375597 · Cited by 514
Self-citationPalmer, S., Kearney, M., Maldarelli, F., Halvas, E. K., Bixby, C. J., Bazmi, H., Rock, D., Falloon, J., Davey, R. T., Dewar, R. L., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.1.406-413.2005 · Cited by 506
Self-citationFätkenheuer, G., Pozniak, A. L., Johnson, M. A., Plettenberg, A., Staszewski, S., Hoepelman, A. I. M., Saag, M. S., Goebel, F. D., Rockstroh, J. K., Dezube, B. J., et al. (2005) · Nature Medicine · doi:10.1038/nm1319 · Cited by 495
HIV-1 Protease Inhibitors Are Substrates for the MDR 1 Multidrug Transporter
Lee, C. G. L., Gottesman, M. M., Cardarelli, C. O., Ramachandra, M., Jeang, K.-T., Ambudkar, S. V., Pastan, I., & Dey, S. (1998) · Biochemistry · doi:10.1021/bi972709x · Cited by 477
HIV-1 Drug Resistance in Newly Infected Individuals
Boden, D. (1999) · JAMA · doi:10.1001/jama.282.12.1135 · Cited by 466
Time Trends in Primary HIV-1 Drug Resistance Among Recently Infected Persons
Grant, R. M. (2002) · JAMA · doi:10.1001/jama.288.2.181 · Cited by 459
Hecht, F. M., Grant, R. M., Petropoulos, C. J., Dillon, B., Chesney, M. A., Tian, H., Hellmann, N. S., Bandrapalli, N. I., Digilio, L., Branson, B., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390504 · Cited by 444
Jensen, M. A., Li, F.-S., van ’t Wout, A. B., Nickle, D. C., Shriner, D., He, H.-X., McLaughlin, S., Shankarappa, R., Margolick, J. B., & Mullins, J. I. (2003) · Journal of Virology · doi:10.1128/jvi.77.24.13376-13388.2003 · Cited by 428
Determinants of Human Immunodeficiency Virus Type 1 Resistance to gp41-Derived Inhibitory Peptides
Rimsky, L. T., Shugars, D. C., & Matthews, T. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.986-993.1998 · Cited by 423
The prevalence of antiretroviral drug resistance in the United States
Richman, D. D., Morton, S. C., Wrin, T., Hellmann, N., Berry, S., Shapiro, M. F., & Bozzette, S. A. (2004) · AIDS · doi:10.1097/01.aids.0000131310.52526.c7 · Cited by 408
Self-citationMarkowitz, M., Nguyen, B.-Y., Gotuzzo, E., Mendo, F., Ratanasuwan, W., Kovacs, C., Prada, G., Morales-Ramirez, J. O., Crumpacker, C. S., Isaacs, R. D., et al. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318157131c · Cited by 408
Replicative Fitness of Protease Inhibitor-Resistant Mutants of Human Immunodeficiency Virus Type 1
Martinez-Picado, J., Savara, A. V., Sutton, L., & D’Aquila, R. T. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3744-3752.1999 · Cited by 396
Lazzarin, A., Campbell, T., Clotet, B., Johnson, M., Katlama, C., Moll, A., Towner, W., Trottier, B., Peeters, M., Vingerhoets, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61048-4 · Cited by 392
Self-citationTransmission of antiretroviral-drug-resistant HIV-1 variants
Yerly, S., Kaiser, L., Race, E., Bru, J.-P., Clavel, F., & Perrin, L. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12262-6 · Cited by 389
Hertogs, K., de Béthune, M.-P., Miller, V., Ivens, T., Schel, P., Van Cauwenberge, A., Van den Eynde, C., van Gerwen, V., Azijn, H., van Houtte, M., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.269 · Cited by 389
Markowitz, M., Morales-Ramirez, J. O., Nguyen, B.-Y., Kovacs, C. M., Steigbigel, R. T., Cooper, D. A., Liporace, R., Schwartz, R., Isaacs, R., Gilde, L. R., et al. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31802b4956 · Cited by 368
Descamps, D. (2000) · JAMA · doi:10.1001/jama.283.2.205 · Cited by 367
Whitcomb, J. M., Huang, W., Fransen, S., Limoli, K., Toma, J., Wrin, T., Chappey, C., Kiss, L. D. B., Paxinos, E. E., & Petropoulos, C. J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00853-06 · Cited by 356
Westby, M., Smith-Burchnell, C., Mori, J., Lewis, M., Mosley, M., Stockdale, M., Dorr, P., Ciaramella, G., & Perros, M. (2007) · Journal of Virology · doi:10.1128/jvi.02006-06 · Cited by 350
Shimura, K., Kodama, E., Sakagami, Y., Matsuzaki, Y., Watanabe, W., Yamataka, K., Watanabe, Y., Ohata, Y., Doi, S., Sato, M., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01534-07 · Cited by 343
Update of the drug resistance mutations in HIV-1: 2007.
Johnson, V. A., Brun‐Vézinet, F., Clotet, B., Günthard, H. F., Kuritzkes, D. R., Pillay, D., Schapiro, J., & Richman, D. D. (2007) · PubMed · Cited by 329
Self-citationHIV-1 protease and reverse transcriptase mutations for drug resistance surveillance
Shafer, R. W., Rhee, S.-Y., Pillay, D., Miller, V., Sandstrom, P., Schapiro, J. M., Kuritzkes, D. R., & Bennett, D. (2007) · AIDS · doi:10.1097/qad.0b013e328011e691 · Cited by 324
Self-citationShioda, T., Levy, J. A., & Cheng-Mayer, C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9434 · Cited by 322
Ledergerber, B. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16589-6 · Cited by 307
Watson, C., Jenkinson, S., Kazmierski, W., & Kenakin, T. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008565 · Cited by 302
Havlir, D. V. (2000) · JAMA · doi:10.1001/jama.283.2.229 · Cited by 297
Esté, J. A., & Telenti, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61052-6 · Cited by 287
Structured Treatment Interruption in Patients with Multidrug-Resistant Human Immunodeficiency Virus
Lawrence, J., Mayers, D. L., Hullsiek, K. H., Collins, G., Abrams, D. I., Reisler, R. B., Crane, L. R., Schmetter, B. S., Dionne, T. J., Saldanha, J. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035103 · Cited by 268
Geno2pheno: estimating phenotypic drug resistance from HIV-1 genotypes
Beerenwinkel, N. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg575 · Cited by 266
Raboud, J. M., Montaner, J. S. G., Conway, B., Rae, S., Reiss, P., Vella, S., Cooper, D., Lange, J., Harris, M., Wainberg, M. A., et al. (1998) · AIDS · doi:10.1097/00002030-199813000-00008 · Cited by 259
Strain, M. C., Günthard, H. F., Havlir, D. V., Ignacio, C. C., Smith, D. M., Leigh-Brown, A. J., Macaranas, T. R., Lam, R. Y., Daly, O. A., Fischer, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0736332100 · Cited by 254
Self-citationLittle, S. J., Frost, S. D. W., Wong, J. K., Smith, D. M., Pond, S. L. K., Ignacio, C. C., Parkin, N. T., Petropoulos, C. J., & Richman, D. D. (2008) · Journal of Virology · doi:10.1128/jvi.02579-07 · Cited by 251
Self-citationGulick, R. M., Su, Z., Flexner, C., Hughes, M. D., Skolnik, P. R., Wilkin, T. J., Gross, R., Krambrink, A., Coakley, E., Greaves, W. L., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/518797 · Cited by 239
Self-citationUse of Genotypic Resistance Testing To Guide HIV Therapy: Clinical Impact and Cost-Effectiveness
Weinstein, M. C., Goldie, S. J., Losina, E., Cohen, C. J., Baxter, J. D., Zhang, H., Kimmel, A. D., & Freedberg, K. A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-6-200103200-00008 · Cited by 235
Arrivé, E., Newell, M.-L., Ekouevi, D. K., Chaix, M.-L., Thiebaut, R., Masquelier, B., Leroy, V., Perre, P. V. D., Rouzioux, C., & Dabis, F. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym104 · Cited by 235
HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture
Brenner, B. G., Oliveira, M., Doualla-Bell, F., Moisi, D. D., Ntemgwa, M., Frankel, F., Essex, M., & Wainberg, M. A. (2006) · AIDS · doi:10.1097/01.aids.0000232228.88511.0b · Cited by 226
Winters, M. A., Coolley, K. L., Girard, Y. A., Levee, D. J., Hamdan, H., Shafer, R. W., Katzenstein, D. A., & Merigan, T. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4948 · Cited by 216
Strizki, J. M., Tremblay, C., Xu, S., Wojcik, L., Wagner, N., Gonsiorek, W., Hipkin, R. W., Chou, C.-C., Pugliese-Sivo, C., Xiao, Y., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.4911-4919.2005 · Cited by 213
Self-citationImpact of drug resistance mutations on virologic response to salvage therapy
Lorenzi, P., Opravil, M., Hirschel, B., Chave, J.-P., Furrer, H.-J., Sax, H., Vaclav Perneger, T., Perrin, L., Kaiser, L., & Yerly, S. (1999) · AIDS · doi:10.1097/00002030-199902040-00001 · Cited by 205
Resch, W., Hoffman, N., & Swanstrom, R. (2001) · Virology · doi:10.1006/viro.2001.1087 · Cited by 202
Kuhmann, S. E., Pugach, P., Kunstman, K. J., Taylor, J., Stanfield, R. L., Snyder, A., Strizki, J. M., Riley, J., Baroudy, B. M., Wilson, I. A., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.2790-2807.2004 · Cited by 196
Sax, P. E., Islam, R., Walensky, R. P., Losina, E., Weinstein, M. C., Goldie, S. J., Sadownik, S. N., & Freedberg, K. A. (2005) · Clinical Infectious Diseases · doi:10.1086/496984 · Cited by 189
Hoffman, N. G., Seillier-Moiseiwitsch, F., Ahn, J., Walker, J. M., & Swanstrom, R. (2002) · Journal of Virology · doi:10.1128/jvi.76.8.3852-3864.2002 · Cited by 170
A Novel Substrate-Based HIV-1 Protease Inhibitor Drug Resistance Mechanism
Nijhuis, M., van Maarseveen, N. M., Lastere, S., Schipper, P., Coakley, E., Glass, B., Rovenska, M., de Jong, D., Chappey, C., Goedegebuure, I. W., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040036 · Cited by 168
Xu, L., Pozniak, A., Wildfire, A., Stanfield-Oakley, S. A., Mosier, S. M., Ratcliffe, D., Workman, J., Joall, A., Myers, R., Smit, E., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1113-1119.2005 · Cited by 166
Self-citationPredicting HIV Coreceptor Usage on the Basis of Genetic and Clinical Covariates
Sing, T., Low, A. J., Beerenwinkel, N., Sander, O., Cheung, P. K., Domingues, F. S., Büch, J., Däumer, M., Kaiser, R., Lengauer, T., et al. (2007) · Antiviral Therapy · doi:10.1177/135965350701200709 · Cited by 162
Yap, S.-H., Sheen, C.-W., Fahey, J., Zanin, M., Tyssen, D., Lima, V. D., Wynhoven, B., Kuiper, M., Sluis-Cremer, N., Harrigan, P. R., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040335 · Cited by 162
Sista, P. R., Melby, T., Davison, D. K., Jin, L., Mosier, S. M., Mink, M., Nelson, E. L., DeMasi, R. A., Cammack, N., Salgo, M., et al. (2004) · AIDS · doi:10.1097/00002030-200409030-00007 · Cited by 154
Persistence of primary drug resistance among recently HIV-1 infected adults
Barbour, J. D., Hecht, F. M., Wrin, T., Liegler, T. J., Ramstead, C. A., Busch, M. P., Segal, M. R., Petropoulos, C. J., & Grant, R. M. (2004) · AIDS · doi:10.1097/01.aids.0000131391.91468.ff · Cited by 153
Günthard, H. F., Wong, J. K., Ignacio, C. C., Havlir, D. V., & Richman, D. D. (1998) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1998.14.869 · Cited by 150
Self-citationXiao, L., Owen, S. M., Goldman, I. F., Lal, A. A., deJong, J. J., Goudsmit, J., & Lal, R. B. (1998) · Virology · doi:10.1006/viro.1997.8924 · Cited by 150
Lü, J., Sista, P. R., Giguel, F. F., Greenberg, M., & Kuritzkes, D. R. (2004) · Journal of Virology · doi:10.1128/jvi.78.9.4628-4637.2004 · Cited by 144
Self-citationNikolenko, G. N., Delviks‐Frankenberry, K. A., Palmer, S., Maldarelli, F. M., Fivash, M. J., Coffin, J. M., & Pathak, V. K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609642104 · Cited by 136
Metzner, K. J., Bonhoeffer, S., Fischer, M., Karanicolas, R., Allers, K., Joos, B., Weber, R. K., Hirschel, B. J., Kostrikis, L. G., Günthard, H. F., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/379215 · Cited by 133
Self-citation14th Conference on Retroviruses and Opportunistic Infections (CROI 2007)
Hirschel, B. J. (2007) · Future HIV Therapy · doi:10.2217/17469600.1.1.13 · Cited by 133
Race, E., Dam, E. M., Obry, V., Paulous, S., & Clavel, F. (1999) · AIDS · doi:10.1097/00002030-199910220-00008 · Cited by 131
Côté, H. C. F., Brumme, Z. L., & Harrigan, P. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.2.589-594.2001 · Cited by 131
von Wyl, V. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.16.1782 · Cited by 131
Mink, M., Mosier, S. M., Janumpalli, S., Davison, D. K., Jin, L., Melby, T. E., Sista, P. R., Erickson, J. B., Lambert, D. M., Stanfield-Oakley, S., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.19.12447-12454.2005 · Cited by 130
DART Virology Group and Trial Team (2006) · AIDS · doi:10.1097/01.aids.0000233572.59522.45 · Cited by 129
Hance, A. J., Lemiale, V., Izopet, J., Lecossier, D., Joly, V., Massip, P., Mammano, F., Descamps, D., Brun‐Vézinet, F., & Clavel, F. (2001) · Journal of Virology · doi:10.1128/jvi.75.14.6410-6417.2001 · Cited by 127
Self-citationA New Perspective on V3 Phenotype Prediction
Pillai, S. K., Good, B. M., Richman, D. D., & Corbeil, J. (2003) · AIDS Research and Human Retroviruses · doi:10.1089/088922203762688658 · Cited by 124
Self-citationBally, F., Martínez, R., Peters, S., Sudre, P., & Telenti, A. (2000) · AIDS Research and Human Retroviruses · doi:10.1089/08892220050116970 · Cited by 123
Musey, L. K., Krieger, J. N., Hughes, J. P., Schacker, T. W., Corey, L., & McElrath, M. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/314868 · Cited by 115
Rapid Emergence of Enfuvirtide Resistance in HIV-1-Infected Patients: Results of a Clonal Analysis
Lü, J., Deeks, S. G., Hoh, R., Beatty, G. W., Kuritzkes, B. A., Martin, J. N., & Kuritzkes, D. R. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000234083.34161.55 · Cited by 114
Self-citationDoualla‐Bell, F., Avalos, A., BRENNER, B. G., Gaolathe, T., Mine, M., Gaseitsiwe, S., Oliveira, M., Moisi, D., Ndwapi, N., Moffat, H., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00714-06 · Cited by 113
Tsibris, A. M. N., Sagar, M., Gulick, R. M., Su, Z., Hughes, M. D., Greaves, W. L., Subramanian, M. G., Flexner, C. W., Giguel, F. F., Leopold, K. E., et al. (2008) · Journal of Virology · doi:10.1128/jvi.00444-08 · Cited by 109
Self-citationPellegrin, I., Izopet, J., Reynes, J., Denayrolles, M., Montès, B., Pellegrin, J., Massip, P., & Puel, J. (1999) · AIDS · doi:10.1097/00002030-199909100-00014 · Cited by 106
Nijhuis, M., Schuurman, R., de Jong, D. C. M., van Leeuwen, R., Lange, J. M. A., Danner, S. A., Keulen, W., de Groot, T. M., & Boucher, C. A. (1997) · The Journal of Infectious Diseases · doi:10.1086/514056 · Cited by 102
Marcelin, A., Lamotte, C., Delaugerre, C., Ktorza, N., Aït-Mohand, H., Cacace, R., Bonmarchand, M., Wirden, M., Simon, A., Bossi, P., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.594-600.2003 · Cited by 98
Côté, H. C. F., Magil, A. B., Harris, M., Scarth, B. J., Gadawski, I., Wang, N., Yu, E., Yip, B., Zalunardo, N., Werb, R., et al. (2006) · Antiviral Therapy · doi:10.1177/135965350601100108 · Cited by 97
Charpentier, C., Dwyer, D. E., Mammano, F., Lecossier, D., Clavel, F., & Hance, A. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.8.4234-4247.2004 · Cited by 93
Casado, J. L., Hertogs, K., Ruiz, L., Dronda, F., Cauwenberge, A. V., Arnó, A., García-Arata, I., Bloor, S., Bonjoch, A., Blázquez, J., et al. (2000) · AIDS · doi:10.1097/00002030-200001280-00001 · Cited by 92
Self-citationMyint, L., Matsuda, M., Matsuda, Z., Yokomaku, Y., Chiba, T., Okano, A., Yamada, K., & Sugiura, W. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.444-452.2004 · Cited by 85
Brehm, J. H., Koontz, D. L., Meteer, J. D., Pathak, V. K., Sluis‐Cremer, N., & Mellors, J. W. (2007) · Journal of Virology · doi:10.1128/jvi.02203-06 · Cited by 84
Self-citationDelviks‐Frankenberry, K. A., Nikolenko, G. N., Barr, R., & Pathak, V. K. (2007) · Journal of Virology · doi:10.1128/jvi.02820-06 · Cited by 81
Truong, H. M., Grant, R. M., McFarland, W., Kellogg, T. A., Kent, C. K., Louie, B. E., Wong, E., & Klausner, J. D. (2006) · AIDS · doi:10.1097/01.aids.0000252059.85236.af · Cited by 78
Vora, S., Marcelin, A., Günthard, H. F., Flandre, P., Hirsch, H. H., Masquelier, B., Zinkernagel, A. S., Peytavin, G., Cálvez, V., Perrin, L. H., et al. (2005) · AIDS · doi:10.1097/01.aids.0000196179.11293.fc · Cited by 67
Self-citationNelson, J. A., Fiscus, S. A., & Swanstrom, R. I. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8750-8758.1997 · Cited by 66
Insulin Resistance, Glucose Intolerance and Diabetes Mellitus in HIV-Infected Patients
Florescu, D. F., & Kotler, D. P. (2007) · Antiviral Therapy · doi:10.1177/135965350701200214 · Cited by 64
Estimating HIV‐1 Drug Resistance in Antiretroviral‐Treated Individuals in the United Kingdom
UK Collaborative Group on HIV Drug Resistance (2005) · The Journal of Infectious Diseases · doi:10.1086/432763 · Cited by 62
Resistance to antiretroviral drugs in patients with primary HIV-1 infection
BRENNER, B. G., Wainberg, M. A., Salomón, H., Rouleau, D., Dascal, A., Spira, B., Sékaly, R., Conway, B., & Routy, J. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00270-3 · Cited by 61
Protease inhibition in African subtypes of HIV-1.
Velázquez‐Campoy, A., Vega, S., Fleming, E. E., Bacha, U., Sayed, Y., Dirr, H. W., & Freire, E. (2003) · PubMed · Cited by 52
Marcelin, A., Cohen-Codar, I., King, M. S., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1720-1726.2005 · Cited by 52
von Wyl, V., Yerly, S., Böni, J., Bürgisser, P., Klimkait, T., Battegay, M., Bernasconi, E., Cavassini, M. L., Furrer, H., Hirschel, B. J., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/528863 · Cited by 48
Self-citationNaeger, L. K., & Struble, K. A. (2006) · AIDS · doi:10.1097/01.aids.0000218548.77457.76 · Cited by 46
Chaix, C., Grenier‐Sennelier, C., Clevenbergh, P. A., Durant, J., Schapiro, J., Dellamonica, P., & Durand‐Zaleski, I. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200007010-00005 · Cited by 46
Self-citationSendi, P., Günthard, H. F., Simcock, M., Ledergerber, B., Schüpbach, J., Battegay, M., & Study, F. T. S. H. C. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000173 · Cited by 44
Self-citationMarcelin, A., Reynes, J., Yerly, S., Ktorza, N., Segondy, M., Piot, J.-C., Delfraissy, J., Kaiser, L., Perrin, L. H., Katlama, C., et al. (2004) · AIDS · doi:10.1097/00002030-200406180-00015 · Cited by 40
Kaufmann, G. R., Suzuki, K., Cunningham, P., Mukaide, M., Kondo, M., Imai, M., Zaunders, J., & Cooper, D. A. (2001) · AIDS Research and Human Retroviruses · doi:10.1089/08892220151126526 · Cited by 38
TMC125 exerts similar initial antiviral potency as a five-drug, triple class antiretroviral regimen
Sankatsing, S. U., Weverling, G. J., Peeters, M., Klooster, G. A. E. V. '., Груздев, Б. М., Rakhmanova, A. G., Danner, S. A., Jurriaans, S., Prins, J. M., & Lange, J. M. A. (2003) · AIDS · doi:10.1097/00002030-200312050-00009 · Cited by 38
Corzillius, M., Mühlberger, N., Sroczynski, G., Jaeger, H., Wasem, J., & Siebert, U. (2004) · Antiviral Therapy · doi:10.1177/135965350400900106 · Cited by 33
Roth, Z. B., & Brown, M. M. (2006) · Evidence-Based Ophthalmology · doi:10.1097/01.ieb.0000212051.70761.83 · Cited by 32
Hales, G., Birch, C. J., Crowe, S., Workman, C., Hoy, J., Law, M. G., Kelleher, A. D., Lincoln, D. J., & Emery, S. (2006) · PLoS Clinical Trials · doi:10.1371/journal.pctr.0010018 · Cited by 31
Phillips, B. A., Caspi, O., Murthy, G. D., & Nelson, M. R. (2009) · Cited by 30
Morand‐Joubert, L., Charpentier, C., Poizat, G., et al. (2006) · Antiviral Therapy · doi:10.1177/135965350601100211 · Cited by 23
Wirden, M., Delaugerre, C., Marcelin, A., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.644-647.2004 · Cited by 16
Elion, R., Cohen, C. J., DeJesus, E., Redfield, R., Gathe, J., Hsu, R. K., Yau, L., Ross, L., Ha, B., Lanier, R., et al. (2006) · HIV Clinical Trials · doi:10.1310/974j-8707-4700-1756 · Cited by 12
Cited by
Thompson, M. A., Aberg, J. A., Hoy, J. F., Telenti, A., Benson, C., Cahn, P., Eron, J. J., Günthard, H. F., Hammer, S. M., Reiss, P., et al. (2012) · JAMA · doi:10.1001/jama.2012.7961 · Cited by 2,469
Self-citationAntiretroviral-Drug Resistance among Patients Recently Infected with HIV
Little, S. J., Holte, S., Routy, J.-P., Daar, E. S., Markowitz, M., Collier, A. C., Koup, R. A., Mellors, J. W., Connick, E., Conway, B., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013552 · Cited by 1,140
Self-citationHuman immunodeficiency virus reverse transcriptase and protease sequence database
Rhee, S.-Y. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg100 · Cited by 817
Lennox, J. L., DeJesus, E., Lazzarin, A., Pollard, R. B., Madruga, J. V. R., Berger, D. S., Zhao, J., Xu, X., Williams-Diaz, A., Rodgers, A. J., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60918-1 · Cited by 625
Antiviral Drug Resistance of Human Cytomegalovirus
Lurain, N. S., & Chou, S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00009-10 · Cited by 596
Metadata
- Authors
- Hirsch, M. S., Günthard, H. F., Schapiro, J. M., Brun‐Vézinet, F., Clotet, B., Hammer, S. M., Johnson, V. A., Kuritzkes, D. R., Mellors, J. W., Pillay, D., Yeni, P. G., Jacobsen, D. M., & Richman, D. D.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-07-15
- Volume
- 47
- Issue
- 2
- Pages
- 266-285
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2133758885
- Cited by
- 573
- References
- 126
- FWCI
- 51.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.